PharmaCyte Biotech (PMCB) Stock Insights
PMCB$0.33-0.00 -0.78%
$3.57M
Market Cap
-0.14
P/E
—
Forward P/E
53
Score
PharmaCyte Biotech (PMCB) Stock Insights
PMCB price $0.33 -0.00 -0.78%
- Ticker
- PMCB
- Price
- $0.33
- Change
- -0.00 -0.78%
- Market cap ?
- $3.57M
- P/E ?
- -0.14
- Dividend yield ?
- 0.00%
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 53
- Value
- 56
- Quality
- 52
- Growth
- 50
Stocklytics score rationale: value 56, quality 52, growth 50.
Financials
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
PharmaCyte Biotech, Inc. is a biotechnology firm dedicated to the development and commercialization of advanced cellular therapies within the United States. Their primary therapeutic areas include various forms of cancer, diabetes, and malignant ascites. Central to their efforts is Cell-in-a-Box, their proprietary encapsulation technology which utilizes cellulose to enclose live cells. This innovative platform…
Insights · Dividends · Forecast · Financials · Learn